
Туған жері
FATİH
Тілдер
İNGİLİZCE
2022 - 2026
İstanbul Florence Nightingale Hastanesi
2021 - 2022
İstanbul Özel Başarı Hastanesi
2017 - 2019
Harvard Tıp Fakültesi
2014 - 2017
İstanbul Üniversitesi İstanbul Tıp Fakültesi Genel Cerrahi C Servisi
2012 - 2014
Bitlis Devlet Hastanesi Genel Cerrahi Kliniği
2006
Bitlis Adilcevaz Devlet Hastanesi
2012
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Genel Cerrahi
2006
Kocaeli Üniversitesi, Tıp Fakültesi
1) The management of mesenteric vein thrombosis: a single institution's experience (Yanar F, Ağcaoğlu O,
Gök AF, Sarıcı IS, Ozçınar B, Aksakal N, Aksoy M, Ozkurt E, Kurtoğlu M.) (Ulus Travma Acil Cerrahi
Derg. 2013 May;19(3):223-8. doi:10.5505/tjtes.2013.47542) (PMID: 23720109)
3.5. BİLİMSEL YAYINLAR
7) Retroperitoneal Maligniteyi Taklit Eden Kronik Spontan Retroperitoneal Hematom. (İlhan M, Gok AFK,
Ozkurt E, Kose M, Ertekin C) (İç Hastalıkları Dergisi 2016 Cilt:23 Sayı:2; 119-122).
5) Lymphocytic Mastopathy: Mimicker of Breast Malignancy. (Yilmaz R, Yesil S, Bayramoglu Z, Ozkurt
E, Acunas G.) (Breast J. 2017 Mar;23(2):229-231).
2) Acute myocardial infarction associated with blood transfusion: Case report and literature review
(Velibey Y, Erbay A, Ozkurt E, Usta E, Akin F.) (Transfus Apher Sci. 2014 Jan 17. pii: S1473-
0502(14)00011-1. doi: 10.1016/j.transci.2014.01.009) (PMID: 24462652)
6) Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with
Immediate Breast Reconstruction: 5-year Follow-up. (Özkurt E, Tükenmez M, Güven E, Çelet Özden B,
Öner G, Müslümanoğlu M, İğci A, Özmen V, Küçücük S, Cabioğlu N.) (Balkan Med J. 2017 Sep 29. doi:
10.4274/balkanmedj.2017.0029.).
4) Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of
diffusion-weighted imaging in the differential diagnosis? (Yilmaz R, Demir AA, Kaplan A, Sahin D,
Ozkurt E, Dursun M, Acunas G.) (Radiol Med. 2016 Nov;121(11):857-866)
8) Myofibroblastoma of the Breast: Ultrasonography, Mammography, and Magnetic Resonance Imaging
Features With Pathologic Correlation. (Yilmaz R, Akkavak G, Ozgur E, Onder S, Ozkurt E, Dursun M.)
(Ultrasound Q. 2018 Feb 7. doi: 10.1097/RUQ.0000000000000337.).
9) Surgical Highlights from the 40th San Antonio Breast Cancer Symposium: 5-9 December 2017, San
Antonio, Texas. (Özkurt E) (Eur J Breast Health. 2018 Apr 1;14(2):74-79. doi: 10.5152/ejbh.2018.0202.).
10) Favorable Long-Term Outcome in Male Breast Cancer. (Özkurt E, Tükenmez M, Yilmaz R, Cabioğlu
N, Müslümanoğlu M, Dinççağ A, İğci A, Özmen V) (Eur J Breast Health. 2018; 14: 180-185. doi:
10.5152/ejbh.2018.3946).
Page 15 of 34
11) Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients
Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy. (Cabioğlu N, Karanlık H,
Kangal D, Özkurt E, Öner G, Sezen F, Yılmaz R, Tükenmez M, Önder S, İğci A, Özmen V, Dinççağ A,
Engin G, Müslümanoğlu M) (Ann Surg Oncol. 2018 Jul 5. doi: 10.1245/s10434-018-6575-6.).
19) Özkurt E, Barbaros U, Aksakal N, Doğan S, Bozbora A. Single incision laparoscopic abdominal
surgeries: case series of 155 various procedures, an observational cohort study. Turk J Surg 2020; 36 (4):
353-358.
20) Özkurt E. Factors Affecting Patient Outcomes in Acute Appendicitis in Rural Areas: An Observational
Cohort Study. World J Surg. 2021 Apr 3. doi: 10.1007/s00268-021-06093-5. Epub 2021 Apr 3.
15) National trends of synchronous bilateral breast cancer incidence in the United States. (Sakai T, Özkurt
E, DeSantis S, Wong SM, Rosenbaum L, Zheng H, Golshan M) (Breast Cancer Res Treat.2019
Nov;178(1):161-167. doi: 10.1007/s10549-019-05363-0. Epub 2019 Jul 19.
13) The Effect of Isosulfan Blue Used for Sentinel Lymphnode Biopsy on Methemoglobine Level (Tolga
Totoz, Gulcin Ercan, Sitki N. Sinikoglu, Mustafa Tukenmez, Enver Ozkurt, Oguz Koc, Osman B.
Gulcicek, Yuksel Altinel, Hakan Yigitbas, and Atilla Celik) (Ely J Surg. 2018August:1(2):101.).
14) Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas. (Türkyılmaz Z,
Aydın T, Yılmaz R, Önder S, Özkurt E, Tükenmez M, Müslümanoğlu M, Acunaş G, İğci A, Özmen V,
Dinççağ A, Cabioğlu N) (Eur J Breast Health. 2019 Jul 1;15(3):171-175. doi: 10.5152/ejbh.2019.4624).
16) Survival Outcomes for Patients with Clinical Complete Response After Neoadjuvant Chemotherapy: Is
Omitting Surgery an Option? (Özkurt E, Sakai T, Wong SM, Tükenmez M, Golshan M) (Ann Surg Oncol.
2019 Oct;26(10):3260-3268. doi: 10.1245/s10434-019-07534-1. Epub 2019 Jul 24).
17) ASO Author Reflections: De-escalation of Breast Cancer Surgery: A Leap Forward. (Özkurt E,
Golshan M) (Ann Surg Oncol. 2019 Dec;26(Suppl 3):711-712. doi: 10.1245/s10434-019-07759-0. Epub
2019 Aug 29).
18) Omission of Surgical Axillary Lymph Node Staging in Patients with Tubular Breast Cancer (Özkurt E,
Wong S, Rhei E, Golshan M, Brock J, Barbie TU). Ann Surg Oncol. 2020 Oct 19. doi: 10.1245/s10434-
020-09223-w. Epub 2020 Oct 19.
12) Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
(Enver Ozkurt, Erkan Yardımcı, Mustafa Tükenmez, Yeliz Emine Ersoy, Ravza Yilmaz, Neslihan
Cabioğlu, Hasan Karanlık, Cemil Burak Kulle, Fatma Umit Malya, Semen Önder, Zuhal Gucin, Abdullah
İğci, Vahit Özmen, Ahmet Sait Dinççağ, Mahmut Müslümanoğlu) (Breast J. 2019 Jan;25(1):96-102. doi:
10.1111/tbj.13149. Epub 2018 Nov 12).
Page 16 of 34
26) Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M,
Tukenmez M. Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2
Germline Mutation? Breast Cancer (Dove Med Press). 2023 Feb 21;15:163-173. doi:
10.2147/BCTT.S395054. eCollection 2023.
29) Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T,
Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V. MCM-2 Levels as a Potential
Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification. Breast
Cancer (Dove Med Press). 2023 Sep 1;15:659-669. doi: 10.2147/BCTT.S421535. eCollection 2023.
28) Cabioglu N, Trabulus DC, Emiroglu S, Ozkurt E, Yalcin N, Dinc N, Tukenmez M, Muslumanoglu M,
Igci A, Ozmen V, Dinccag AS, Guven YI. Ozone therapy as a novel complementary therapeutic approach
in refractory idiopathic granulomatous mastitis. Front Med (Lausanne). 2023 Jul 6;10:1174372. doi:
10.3389/fmed.2023.1174372. eCollection 2023.
27) Turkyilmaz Z, Sarisik E, Ozkurt E, Tukenmez M, Emiroglu S, Emiroglu B, Onder S, Yilmaz R,
Muslumanoglu M, Igci A, Ozmen V, Cabioglu N. Evaluation of Benign Breast Diseases With or Without
Atypical Epithelial Hyperplasia Accompanying Radial Scars. Eur J Breast Health. 2023 Apr 1;19(2):166-
171. doi: 10.4274/ejbh.galenos.2023.2022-10-4. eCollection 2023 Apr.
21) Cabıoğlu N, Karanlık H, Yıldırım N, Müslümanoğlu M, Çakmak Karadeniz G, Trabulus Can D,
Tükenmez M, Ersoy YE, Uras C, Zengel B, Emiroğlu S, Polat AK, Yeniay L, Özkurt E, Kara H, İbiş K,
Aydıner A, Özmen V, İğci A. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant
chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTITURK
MF-18-02-study. Eur J Surg Oncol. 2021 Oct;47(10):2506-2514.
25) Özkurt E, Emiroğlu S, Cabioğlu N, Karanlık H, Önder S, Tükenmez M, İğci A, Özmen V,
Müslümanoğlu M. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes.
Breast Care 2022 (DOI:10.1159/000525324). Epub 2022 Jun 2.
22) Özkurt E, İlhan M, Cücük Ö C, Tükenmez M, Cabioğlu N, Müslümanoğlu M E. Neuroendocrıne
carcınoma of the breast: 18 cases wıth long-term follow-up. Journal of Istanbul Faculty of Medicine.
2021;84(4):521-525. https://doi.org/10.26650/IUITFD.2021.830495
23) Cabioglu N, Cetin Aktas E, Emiroglu S, Tukenmez M, Ozkurt E, Muslumanoglu M, Igci A, Ozmen V,
Deniz G, Dinccag AS, Guven YI. Ozone therapy restores immune dysfunction in refractory idiopathic
granulomatous mastitis as a novel potential therapeutic approach. Cell Biol Int. 2022 Nov 15. doi:
10.1002/cbin.11953. Epub 2022 Nov 15.
24) Emiroglu S, Tukenmez M, Karakus S, Karanlik H, Onder S, Ozmen V, Cabioglu N, Ozkurt E, Yilmaz
R, Muslumanoglu M. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical
Outcomes. Eur J Breast Health. 2022 Oct 1;18(4):353-359.
Page 17 of 34
37) Özkurt E, Ordu C, Özmen T, Ilgun AS, Soybir G, Celebi F, Koç E, Ak N, Alco G, Kurt S, Ağaçayak
F, Yavuz E, Tuzlalı S, Ozmen V. Vitamin D Supplementation During Neoadjuvant Chemotherapy for
Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.
World J Surg. 2025 Jun;49(6):1396-1405. doi: 10.1002/wjs.12587. Epub 2025 Apr 14.
38) Cabıoğlu N, Ercan DO, Karataş İ, Eröz E, Toprak S, Emiroğlu S, Hüseynov E, Özkurt E,
Mollavelioğlu B, Tükenmez M, Müslümanoğlu M, İğci A, Özmen V. Changing practice patterns in axillary
management for patients with node-positive breast cancer towards increased use of sentinel lymph node
biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.
Langenbecks Arch Surg. 2025 Jun 16;410(1):196. doi: 10.1007/s00423-025-03767-9.
35) Erdoğan İyigün Z, Ozmen T, İlgün S, Nakipoğlu C, Özkurt E, Çelebi F, Ünal Ç, Öztürk A, Alço G,
Ordu Ç, Soybir G. Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema
Diagnosed in the Preoperative Period via Bioimpedance. Eur J Breast Health. 2025 Jan 1;21(1):40-45. doi:
10.4274/ejbh.galenos.2024.2024-9-5.
36) Cabioglu N, Koçer HB, Karanlik H, Gülçelik MA, Igci A, Müslümanoglu M, Uras C, Mantoglu B,
Trabulus DC, Akgül G, Tükenmez M, Senol K, Özkurt E, et al. De-Escalation of Nodal Surgery in
Clinically Node-Positive Breast Cancer. JAMA Surg. 2025 Mar 1;160(3):257-266. doi:
10.1001/jamasurg.2024.5913.
33) Muslumanoglu M, Cabioglu N, Igci A, Karanlık H, Kocer HB, Senol K, Mantoglu B, Tukenmez M,
Çakmak GK, Ozkurt E, et al. Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies:
ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with
a good response to neoadjuvant chemotherapy as long as radiotherapy is provided. Cancer. 2024 Oct 30.
doi: 10.1002/cncr.35610.
34) Cabioglu N, Karanlik H, Igci A, Muslumanoglu M, Gulcelik MA, Uras C, Kocer HB, Trabulus DC,
Ozkurt E, et al. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-
02/18-03. Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16472-6.
30) Ünal Ç, Ordu Ç, Özmen T, İlgun AS, Çelebi F, Baysal B, Özkurt E, Duymaz T, Erdoğan İyigün Z,
Kurt S, Öztürk MA, Pilancı KN, Alço G, Yararbaş K, Kayan Tapan T, Güven DC, Soybir G, Özmen V.
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in
Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study. Curr
Oncol. 2023 Oct 19;30(10):9217-9229. doi: 10.3390/curroncol30100666.
32) Kayan Tapan T, Çelebi F, Yaghouti K, Ağaçayak F, İlgün S, Soybir G, Alço G, Ak N, Ordu Ç, Özkurt
E, Ünal Ç, Kurt S, Öztürk A, İyigün Z, Duymaz T, Özmen V. The Relationship of Pathological Response
and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant
Chemotherapy. Eur J Breast Health. 2024 Apr 1;20(2):117-121. doi: 10.4274/ejbh.galenos.2024.2023-12-5.
eCollection 2024 Apr.
31) Kurt S, İlgün AS, Özkurt E, Soybir G, Alço G, Ünal Ç, Çelebi FE, Duymaz T, Tapan TK, Ak N, Ordu
Ç, Özmen V. Outcomes of reconstructive techniques in breast cancer using BCCT. core software. World J
Surg Oncol. 2024 Mar 23;22(1):82. doi: 10.1186/s12957-024-03343-3.
Page 18 of 34
39) Cabıoğlu N, Karanlık H, Özmen V, Tükenmez M, İğci A, Aytin YE, Köksal H, Mutlu H, Bademler S,
Uras C, Dülgeroğlu O, Özkurt E, et al. Omitting Axillary Dissection in Triple-Negative and HER2-
Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURKOTHELLO
Study. Clin Breast Cancer. 2025 Jul;25(5):455-463. doi: 10.1016/j.clbc.2025.02.002. Epub
2025 Feb 8.
40) Özkurt E, Ordu Ç, Koç E, Gokmen E, Ozdogan M, Guler N, Uras C, Öz B, Demircan O, Isikdogan A,
Saip P, Ozmen V. Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence
Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to
Different Cut-Offs. World J Surg. 2025 Sep;49(9):2303-2313. doi: 10.1002/wjs.70025. Epub 2025 Aug 1.
41) Cabıoğlu N, Karanlık H, Iğci A, Müslümanoğlu M, Gürsoy OM, Tükenmez M, Polat NC, Özkurt E,
Emiroğlu S, Yıldırım N, Ilgün AS, Önder S, Yılmaz R, Dursun M, Simşek DH, Saip P, Aydıner A, Bayram
A, Mollavelioğlu B, Ibiş K, Küçücük S, Özmen V. Factors Predicting Additional Residual Nodal Disease
With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.
J Breast Cancer. 2025 Oct;28(5):322-332. doi: 10.4048/jbc.2025.0052. Epub 2025 Aug 5.
42) Karadeniz Cakmak G, Tali U, Balbaloglu H, Tasdoven I, Ozkurt E, Karanlik H, et al. Causes of
diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and
electronic health records analysis in Turkiye. Eur J Public Health. 2025 Dec 1;35(6):1271-1280. doi:
10.1093/eurpub/ckaf108.
43) Cabıoğlu N, Türkyılmaz Z, Özkurt E, İğci A, Müslümanoğlu M, Kapkaç M, Yeniay L, et al. Poor
Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish
National Breast Cancer Registry Study. Asian Pac J Cancer Prev. 2025 Dec 1;26(12):4407-4417. doi:
10.31557/APJCP.2025.26.12.4407.
44) Vusal Aliyev, Zeliha Turkyılmaz, Enver Özkurt, Mehmet Durmus Kurt, Mustafa Tukenmez, Selman
Emiroglu, Sibel Ozkan Gurdal, Beyza Ozcinar, Fatih Levent Balci, Omer Bender, Mahmut Muslumanoglu
and Neslihan Cabioglu. Ductoscopy Facilitates Surgical Decision-Making in Management of Patients with
Pathological Nipple Discharge. Diagnostics 2026, 16(6), 856; DOI: 10.3390/diagnostics16060856.